Recent Headlines
3D Preclinical Ultrasound Imaging System Launched in North America and Europe by Scintica Instrumentation
A 3D ultrasound imaging system for mice, rats and other small animals is now available to scientists throughout North America and Europe. The Prospect T1 is a cost effective, tablet based, high-frequency ultrasound imaging system, optimized to study hemodynamics and vascular function at the laboratory benchtop instead of from inside a core imaging facility. Scintica Instrumentation has the exclusive rights to sell and service the Prospect T1 with its team of scientific experts. - February 14, 2019 - Scintica Instrumentation Inc.
ALPCO Announces January 2019 Young Investigator Award Recipient of Its Diabetes Research Travel Grant
ALPCO awards its January 2019 Diabetes Research Travel Grant to Lisa Volpatti at Massachusetts Institute of Technology. - February 05, 2019 - ALPCO
Perthera, Inc. Announces the Appointment of Gary L. Gregory as Chief Executive Officer, President and Board Member
Mr. Gregory is recognized as a proven executive leader with big company capabilities and a keen start-up mindset, and his achievements include executing a successful IPO, driving substantial revenue & earning multiples for a publicly traded company, marshalling medical technologies through positive M&A efforts, and generating $50M+ in corporate financing efforts. - February 04, 2019 - Perthera, Inc.
Red Pill Medical, Inc. Introduces New CBD Product Line to Combat the Common Problems Americans with an Active Lifestyle Face Everyday
Red Pill Medical's CEO Gregory A. Smith, M.D. (Producer of the American Addict films) has rolled out a new science-based line of CBD products designed for everyday use to address a variety of common complaints to help people reach their personal peak. - January 31, 2019 - Red Pill Medical, Inc.
Paras Biopharmaceuticals Finland Oy Announces Successful Development of Biologically Active Romiplostim (N-Plate® Biosimilar) Production Technology
Paras Biopharmaceuticals Finland Oy today announced the achievement of a major milestone – the successful development of biologically active Romiplostim (N-Plate® biosimilar) production technology. Romiplostim has been produced with a proprietary and innovative continuous manufacturing... - January 31, 2019 - Paras Biopharmaceuticals Finland Oy
The Pediatric Cancer Research Foundation Welcomes Two New Board Members in the Fight Against Pediatric Cancer
The Pediatric Cancer Research Foundation announces the addition of two new Board of Directors in 2019. - January 26, 2019 - Pediatric Cancer Research Foundation
Announcing Protectival - A Natural Way to Boost the Immune System and Enhance Cellular Health
After 15 year of research in collaboration with renowned Oncologists and Scientists, LifeBiotic is launching Protectival, a natural product boosting immunity and cellular health. - January 26, 2019 - Lifebiotic
The Pediatric Cancer Research Foundation Funds 9 New Research Grants in 2019
The Pediatric Cancer Research Foundation announces its new 2019 grantees in the fight against pediatric cancer. - January 17, 2019 - Pediatric Cancer Research Foundation
Bioquark Inc. and Ectocrine Technologies LLC to Collaborate on Mosquito-Derived Health Product Development
The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. - January 12, 2019 - Bioquark Inc.
ReproTech, Ltd. Awarded AATB Accreditations
ReproTech, Ltd.’s three facilities, in Minnesota, Florida and Nevada, have again been awarded the prestigious accreditation of the American Association of Tissue Banks (AATB), as well as its Texas facility receiving first-time AATB accreditation, it was announced in December, 2018 by Brent... - January 11, 2019 - ReproTech, LLC
The Cardiac & Vascular Institute and North Florida Regional Medical Center Join Together in a Clinical Trial to Test an Innovative Artificial Intelligence (AI) Device
The Cardiac & Vascular Institute (TCAVI) and North Florida Regional Medical Center (NFRMC) collaborated this week to test an artificial intelligence (AI) device designed to alert clinicians to bleeding episodes during endovascular procedures. According to a press release, the AI device, (named... - January 09, 2019 - The Cardiac & Vascular Institute
Scintica Instrumentation to Distribute the Compact and Affordable MRI Preclinical System from Aspect Imaging
Scintica Instrumentation Inc. is excited to announce their distribution agreement in North America and Europe for Aspect Imaging’s preclinical M-Series™ Compact MRI system. The M-Series™ enable high-resolution 3D imaging without the need for special shielding, cryogens or water connections. Gold standard and affordable MR imaging can now be integrated into individual scientific laboratories, allowing researchers to harness the power and insights of MRI quickly and easily. - January 09, 2019 - Scintica Instrumentation Inc.
GeneFluidics Selected as One of Five Finalists for Antimicrobial Resistance Diagnostic (AMR) Challenge Step 2
GeneFluidics is the only group selected for both NIAID antimicrobial resistance diagnostics projects (https://www.nih.gov/news-events/news-releases/nih-funds-nine-antimicrobial-resistance-diagnostics-projects) and as finalists for the NIH AMR Challenge Step 2 (https://dpcpsi.nih.gov/AMRChallenge/Finalists). - December 05, 2018 - GeneFluidics Inc.
Delk Enterprises, Inc. Acquires Interest in the International Peptide Society (IPS)
Venture capital firm announces transaction in online digital platform, investment to lead to strategic growth in the integrative medical space. - November 23, 2018 - International Peptide Society
New Horizons for Laser Therapy: ASAlaser Presents MiS – MLS® High Peak Pulse
The company from Vicenza, (Italy), a leader in the production of laser therapy, launches a new high-performing device at “Medica 2018” which offers early and scientifically proven results by combining the synchronised action of MLS® Laser Therapy with the pulse power of Hilterapia®. - November 20, 2018 - ASA srl
Wheeling Hospital First in U.S. to Use Surgical Device Tracking System
Wheeling Hospital has become the first U.S. medical facility to use the Matrix IT’s TRACTUS Scanner system to enhance the tracking of surgical implantable devices. Wheeling Hospital was selected to conduct trials of Matrix IT’s TRACTUS Scanner system. The surgical implantable devices... - November 15, 2018 - Matrix Medical Tracking Systems
Fertility Preservation Network Sponsors 2018 Cancer Fundraiser Event Teams
ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian/testicular tissue), was proud to sponsor local staff in multiple 2018 cancer research fundraisers. - November 09, 2018 - ReproTech, LLC
NCHS Celebrates Mission Mesa Women’s Health Ribbon-Cutting Ceremony
North County Health Services Reveals Recent Remodel. - November 01, 2018 - NCHS
ProPath to Participate in National Compliance and Ethics Week; Planned Events to Focus on the Importance of Acting Lawfully and Ethically
Corporate Compliance and Ethics Week, November 4-10, 2018 - November 01, 2018 - ProPath
ALPCO Launches FDA Class I Exempt STELLUX® Glucagon ELISA
ALPCO announces launch of its new highly specific FDA Class I Exempt STELLUX® Chemi Glucagon ELISA. - October 23, 2018 - ALPCO
Credo Biomedical to Present at Animal Health Innovation Summit
Credo Biomedical is one of the 12 finalists that have been selected to showcase during the Animal Health Innovation Summit in Hong Kong. - October 21, 2018 - Credo Biomedical Pte. Ltd.
Epitope Diagnostics, Inc. Certifies Its Total 25-OH Vitamin D EIA Kit Through the CDC’s Vitamin D Standardization-Certification Program (VDSCP)
Epitope Diagnostics, Inc. (EDI), is pleased to announce it has received certification for the Vitamin D Standardization Program (VDSP) for vitamin D measurement in the EDI™ Total 25-OH Vitamin D EIA Kit. CDC’s Vitamin D Standardization-Certification Program (VDSCP) evaluates the... - October 21, 2018 - Epitope Diagnostics, Inc.
Energy for Health, ASAlaser's Scientific Review: 10 Years Marked by Research, Dissemination and Promotion of Scientific Knowledge
A new finish line accomplished for ASAlaser, whose scientific magazine celebrates its first ten years in 2018. The magazine represents just one of the company’s initiatives for highlighting research, the focal point of its growth and the basis of its ethics. - October 19, 2018 - ASA srl
ALPCO Announces Inaugural Young Investigators Award Recipient
ALPCO announces the first recipient of its new young investigators award, the Diabetes Research Travel Grant. - October 17, 2018 - ALPCO
Can't Smell Anything? This Clinical Trial May Give You Hope.
We often take for granted the ability to smell, but people with a diminished sense of smell or who have lost this sense completely know that this ability is linked to our overall quality of life. It is a major contributor to our ability to taste food, and people who lose their sense of smell often lose their appetite. This clinical trial may give them hope. - October 15, 2018 - Foundation for Regenerative Medicine
ALPCO’s Quality Management System Receives ISO 13485:2016 Certification
ALPCO announces that its quality management system recently received the distinguished ISO 13485:2016 certification from Intertek to ensure the quality, safety and efficacy of its products in the clinical diagnostics field. - October 09, 2018 - ALPCO
ProPath Selected as Medical Director for Baylor Scott & White Medical Center – Sunnyvale
ProPath is pleased to announce that they have been selected as the pathology service provider for Baylor Scott & White Medical Center – Sunnyvale. In addition, ProPath’s Dr. Isabel Hill has been named Medical Director of Pathology Services. “ProPath is excited to provide the... - October 04, 2018 - ProPath
ASAlaser Therapies and the Italian Fencing Federation: 10 Years of Medals
The Olympics, the World Championships and international competitions distinguished by victories have marked the ten years of collaboration between the Italian company ASAlaser from Vicenza, manufacturer of lasers for rehabilitation and physiotherapy, and the Azzurri Italian fencing team. These were also underlined by the recent successes at Wuxi 2018. - September 27, 2018 - ASA srl
Epitope Diagnostics, Inc. Joins MetroConnect to Expand International Growth
Epitope Diagnostics, Inc. is pleased to announce it has been selected to take part in MetroConnect 2018, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth. This program will allow Epitope Diagnostics... - September 23, 2018 - Epitope Diagnostics, Inc.
Julien Dagenais, M.D. and Christopher Dru, M.D., Join The Urology Center of Colorado
The addition of the two new urologists/robotic surgeons will bring The Urology Center of Colorado (TUCC) to a total of 18 physicians and 4 advanced practice providers to remain the largest urology group in Colorado. All TUCC physicians are sub-specialists committed to providing excellence at every encounter. - September 21, 2018 - The Urology Center of Colorado
Fertility Preservation Network Welcomes Dallas, Texas Facility
Program greatly extends access to fertility preservation services. - September 20, 2018 - ReproTech, LLC
VirtuOx and Brightree Launch Diagnostic Testing Integration
VirtuOx, one of the world’s largest home diagnostic testing providers, and Brightree®, the leading provider of cloud-based healthcare software and solutions for the post-acute market, have announced a completed integration that enables streamlined workflows for home medical equipment... - September 17, 2018 - VirtuOx
Recovery Unplugged to be Featured in USA Today for “Three Moms” Campaign
Recovery Unplugged Treatment Centers is being featured in USA Today's Addiction and Mental Health Awareness issue on Thursday, September 13th. The "Three Stories" multimedia campaign created by Recovery Unplugged highlights the stories of three mothers and their children who have made it to the other side of addiction - together. - September 08, 2018 - Recovery Unplugged
Recovery Unplugged Kicks Off National Recovery Month Campaign
Recovery Unplugged Treatment Centers kicked-off a multimedia marketing campaign in observance of National Recovery Month. The campaign aims to promote awareness, education, and empowerment throughout the recovery community and their loved ones. Content is being created that celebrate those in recovery, provide information to help people stay clean, and educate loved ones about treatment and the recovery process. - September 08, 2018 - Recovery Unplugged
Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland - XXIII Biennial Meeting of the International Society for Eye Research September 9-13, 2018 | Belfast
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
Trial Runners Strengthens Its Leadership Team
Trial Runners is pleased to announce additions to their executive team as well as their leadership team as a result of a fast-paced growth year. - August 17, 2018 - Trial Runners
ClinTex CTi Leverages Distributed Ledger Technology to Lower the Cost of Medicine
CTi (Clinical Trials Intelligence) aims to bring down the cost of medicine, as well as increase the speed of access to new medicine, by reducing development costs for the global pharmaceutical industry. - August 08, 2018 - ClinTex Ltd
ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical Lab Expo
ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo. - July 25, 2018 - ALPCO
ALPCO and InSphero Partner to Offer a Complete Solution to Assess Beta-cell Function in Islet Microtissue Culture Models
ALPCO and InSphero announce partnership to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. - July 24, 2018 - ALPCO
The Summer Season is Safe for Sufferers of "Swimmer’s Shoulder" Thanks to ASAlaser Therapies
The ASAlaser therapeutic solutions are an effective answer in order to successfully treat one of the most common issues for freestyle and backstroke lovers. Hilterapia® and MLS® provide a fast reduction in pain and a speedy recovery of the joint’s action. - July 22, 2018 - ASA srl
Cayman Partners with LIPID MAPS® to Support Continued Development of Key Lipidomic Research Resources
Cayman has increased its financial support of the LIPID MAPS® Lipidomics Gateway. The newly launched LIPID MAPS® website (June 2018) provides easy access to free tools and resources, including a searchable lipid structure database (with over 43,000 entries), mass spectrometry spectra prediction tools, lipid structure drawing tools, experimental protocols, systems biology pathway maps, statistical analysis tools, and a curated lipid standards database. - July 21, 2018 - Cayman Chemical Company
New Assay for Immunology Research Quantifies cGAS-Produced 2’3’-cGAMP in Cells
Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive... - July 20, 2018 - Cayman Chemical Company
Leaders from Pfizer, Sanofi, Eli Lilly and Applied Informatics to Speak on Artificial Intelligence at Pharma Innovation Conference
Dr. Chintan Patel to discuss the implementation of AI & machine learning in clinical development. - July 19, 2018 - Applied Informatics
Minus K Technology Announces Sixth U.S. Educational Giveaway
Celebrating its 25th year in business Minus K Technology, Inc. is giving away $20,000* worth of patented vibration isolators to colleges within the United States. - July 18, 2018 - Minus K Technology Inc.
ALPCO Releases STELLUX® Chemi Active GLP-1 (7-36) Amide ELISA to Accurately Quantify Fasted Levels
ALPCO, a leading producer of research and clinical immunoassays, recently announced the launch of its STELLUX® Chemi Active GLP-1 (7-36) amide ELISA. The chemiluminescence ELISA features increased sensitivity to accurately quantify active GLP-1 (7-36) amide levels as low as 1.5 pg/mL with a 25... - July 17, 2018 - ALPCO
Dr. Alan Michelson to Advise LightIntegra Technology
Platelet expert, Dr. Alan Michelson has begun consulting as a Scientific Advisor to LightIntegra Technology, the creators of the ThromboLUX System. - June 26, 2018 - LightIntegra Technology
Speakers Inspire Audience at Regional Conference on Necrotizing Enterocolitis
The inaugural Speaking of NEC: Unplugged event, a one-day regional conference focused on identifying practical solutions for reducing the devastating effects of Necrotizing Enterocolitis (NEC) on premature infants and their families took place on June 11, 2018 at the Courtyard by Marriott in... - June 20, 2018 - The Morgan Leary Vaughan Fund, Inc.
ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 22-26, 2018 in Orlando, FL. - June 19, 2018 - ALPCO
Perthera to Exhibit at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
Perthera, Inc., the leading Therapeutics Intelligence Company™, is attending the 2018 ASCO Annual Meeting at McCormick Place, Chicago, IL, June 1-5, 2018. Perthera science and clinical results will be represented in a Podium Presentation, 2 Poster Presentations and a Symposium Breakfast. - May 30, 2018 - Perthera, Inc.
Book on New Way of Doing Medicine Could Save Lives
Adult Stem Cell Released Molecules is a new book on therapeutic development and medicine, by California author Dr. Greg Maguire, Ph.D., that could save lives and restore health. Dr. Greg Maguire's book offers a radically new approach to the standard means of developing therapeutics through the use of the molecules that stem cells release, emphasizing that the molecules act in the organisms through their collective actions within and between all levels of the system, often not at the genome. - May 23, 2018 - BioRegenerative Sciences, Inc.